CAS No. |
163047-23-2 |
|---|---|
中文名称 |
(2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5R,6R)-4,5-二羟基-2-[[(2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aR,12R,12aS,12bR)-12-羟基-5',6a,8a,9-四甲基二十二氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇 |
英文名称 |
(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5R,6R)-4,5-Dihydroxy-2-(((2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aR,12R,12aS,12bR)-12-hydroxy-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyr |
别名 |
Anemarrhenasaponin III;β-D-Galactopyranoside, (3β,5β,15α,25S)-15-hydroxyspirostan-3-yl 2-O-β-D-glucopyranosyl- |
标准英文名 |
(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5R,6R)-4,5-dihydroxy-2-(((2aR,4S,5'S,6aS,6bS,8aS,8bR,9S,10R,11aR,12R,12aS,12bR)-12-hydroxy-5',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
MDL No. |
- |
分子式 |
C39H64O14 |
分子量 |
756.93 |
精确分子量 |
756.43 |
SMILES |
C[C@H]1CC[C@@]2(OC1)O[C@H]1[C@H](O)[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C |
标准SMILES |
C[C@@H]1CO[C@]2(CC1)O[C@@H]1[C@H]([C@@H]2C)[C@@]2(C)CC[C@H]3[C@@H](CC[C@@H]4C[C@H](CC[C@@]43C)O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2[C@H]1O |
性状 |
No data available |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
FZEHHXRFTMAICH-DCZAGIEQSA-N |
危险类别(旧) |
H301 |
存储要求 |
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral , acute toxicity, dermal and acute toxicity, inhalation(Category 3) |
|---|---|
UN No. |
2811,2811,2811 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|